Alcoholic hepatitis: Translational approaches to develop targeted therapies
Open Access
- 3 March 2016
- journal article
- review article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 64 (4) , 1343-1355
Abstract
Alcoholic liver disease is a leading cause of liver‐related mortality worldwide. In contrast to recent advances in therapeutic strategies for patients with viral hepatitis, there is a significant lack of novel therapeutic options for patients with alcoholic liver disease. In particular, there is an urgent need to focus our efforts on effective therapeutic interventions for alcoholic hepatitis (AH), the most severe form of alcoholic liver disease. AH is characterized by an abrupt development of jaundice and complications related to liver insufficiency and portal hypertension in patients with heavy alcohol intake. The mortality of patients with AH is very high (20%‐50% at 3 months). Available therapies are not effective in many patients, and targeted approaches are imminently needed. The development of such therapies requires translational studies in human samples and suitable animal models that reproduce the clinical and histological features of AH. In recent years, new animal models that simulate some of the features of human AH have been developed, and translational studies using human samples have identified potential pathogenic factors and histological parameters that predict survival. Conclusion: This review summarizes the unmet needs for translational studies on the pathogenesis of AH, preclinical translational tools, and emerging drug targets to benefit the AH patient. (Hepatology 2016;64:1343‐1355)Keywords
This publication has 61 references indexed in Scilit:
- Binge Ethanol and Liver: New Molecular DevelopmentsAlcohol, Clinical and Experimental Research, 2013
- IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in miceJournal of Clinical Investigation, 2012
- Alcoholic Liver Disease: Pathogenesis and New Therapeutic TargetsGastroenterology, 2011
- An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: Regulation of proinflammatory cytokines and hepatic steatosis in miceHepatology, 2010
- Enteric dysbiosis associated with a mouse model of alcoholic liver diseaseHepatology, 2010
- Complement and Alcoholic Liver Disease: Role of C1q in the Pathogenesis of Ethanol-Induced Liver Injury in MiceGastroenterology, 2010
- Signalling pathways in alcohol-induced liver inflammationJournal of Hepatology, 2009
- A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic HepatitisGastroenterology, 2008
- Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot studyAlcohol, 2008
- Prevention of the acute ethanol-induced fatty liver by the simultaneous administration of antioxidantsLife Sciences, 1964